Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 217

1.

A Window Into Clinical Next-Generation Sequencing-Based Oncology Testing Practices.

Nagarajan R, Bartley AN, Bridge JA, Jennings LJ, Kamel-Reid S, Kim A, Lazar AJ, Lindeman NI, Moncur J, Rai AJ, Routbort MJ, Vasalos P, Merker JD.

Arch Pathol Lab Med. 2017 Dec;141(12):1679-1685. doi: 10.5858/arpa.2016-0542-CP. Epub 2017 Oct 13.

PMID:
29028368
2.

A Model Study of In Silico Proficiency Testing for Clinical Next-Generation Sequencing.

Duncavage EJ, Abel HJ, Merker JD, Bodner JB, Zhao Q, Voelkerding KV, Pfeifer JD.

Arch Pathol Lab Med. 2016 Oct;140(10):1085-91. doi: 10.5858/arpa.2016-0194-CP. Epub 2016 Jul 7.

PMID:
27388684
3.

Multi-Institutional FASTQ File Exchange as a Means of Proficiency Testing for Next-Generation Sequencing Bioinformatics and Variant Interpretation.

Davies KD, Farooqi MS, Gruidl M, Hill CE, Woolworth-Hirschhorn J, Jones H, Jones KL, Magliocco A, Mitui M, O'Neill PH, O'Rourke R, Patel NM, Qin D, Ramos E, Rossi MR, Schneider TM, Smith GH, Zhang L, Park JY, Aisner DL.

J Mol Diagn. 2016 Jul;18(4):572-9. doi: 10.1016/j.jmoldx.2016.03.002. Epub 2016 May 4.

PMID:
27155050
4.

Trends in Cervical Cytology Screening and Reporting Practices: Results From the College of American Pathologists 2011 PAP Education Supplemental Questionnaire.

Crothers BA, Darragh TM, Tambouret RH, Nayar R, Barkan GA, Zhao C, Booth CN, Padmanabhan V, Tabatabai ZL, Souers RJ, Thomas N, Wilbur DC, Moriarty AT.

Arch Pathol Lab Med. 2016 Jan;140(1):13-21. doi: 10.5858/arpa.2015-0004-CP. Epub 2015 Jun 5.

PMID:
26046490
5.

Marked Variability in Reported Minimal Residual Disease Lower Level of Detection of 4 Hematolymphoid Neoplasms: A Survey of Participants in the College of American Pathologists Flow Cytometry Proficiency Testing Program.

Keeney M, Halley JG, Rhoads DD, Ansari MQ, Kussick SJ, Karlon WJ, Mehta KU, Dorfman DM, Linden MA.

Arch Pathol Lab Med. 2015 Oct;139(10):1276-80. doi: 10.5858/arpa.2014-0543-CP. Epub 2015 Feb 19.

PMID:
25695342
6.

Practical aspects of NGS-based pathways analysis for personalized cancer science and medicine.

Kotelnikova EA, Pyatnitskiy M, Paleeva A, Kremenetskaya O, Vinogradov D.

Oncotarget. 2016 Aug 9;7(32):52493-52516. doi: 10.18632/oncotarget.9370. Review.

7.

Precision medicine and oncology: an overview of the opportunities presented by next-generation sequencing and big data and the challenges posed to conventional drug development and regulatory approval pathways.

Doherty M, Metcalfe T, Guardino E, Peters E, Ramage L.

Ann Oncol. 2016 Aug;27(8):1644-6. doi: 10.1093/annonc/mdw165. Epub 2016 Apr 26. No abstract available.

PMID:
27117532
8.
9.

College of American Pathologists' laboratory standards for next-generation sequencing clinical tests.

Aziz N, Zhao Q, Bry L, Driscoll DK, Funke B, Gibson JS, Grody WW, Hegde MR, Hoeltge GA, Leonard DG, Merker JD, Nagarajan R, Palicki LA, Robetorye RS, Schrijver I, Weck KE, Voelkerding KV.

Arch Pathol Lab Med. 2015 Apr;139(4):481-93. doi: 10.5858/arpa.2014-0250-CP. Epub 2014 Aug 25.

PMID:
25152313
10.

Assuring the Quality of Next-Generation Sequencing in Clinical Microbiology and Public Health Laboratories.

Gargis AS, Kalman L, Lubin IM.

J Clin Microbiol. 2016 Dec;54(12):2857-2865. Epub 2016 Aug 10. Review.

11.

Prevalence of Traditional and Reverse-Algorithm Syphilis Screening in Laboratory Practice: A Survey of Participants in the College of American Pathologists Syphilis Serology Proficiency Testing Program.

Rhoads DD, Genzen JR, Bashleben CP, Faix JD, Ansari MQ.

Arch Pathol Lab Med. 2017 Jan;141(1):93-97. doi: 10.5858/2016-0110-CP. Epub 2016 Oct 20.

PMID:
27763779
12.

Laboratory compliance with the American Society of Clinical Oncology/College of American Pathologists human epidermal growth factor receptor 2 testing guidelines: a 3-year comparison of validation procedures.

Dyhdalo KS, Fitzgibbons PL, Goldsmith JD, Souers RJ, Nakhleh RE.

Arch Pathol Lab Med. 2014 Jul;138(7):876-84. doi: 10.5858/arpa.2013-0731-CP.

PMID:
24978913
13.

In Silico Proficiency Testing for Clinical Next-Generation Sequencing.

Duncavage EJ, Abel HJ, Pfeifer JD.

J Mol Diagn. 2017 Jan;19(1):35-42. doi: 10.1016/j.jmoldx.2016.09.005. Epub 2016 Nov 15. Review.

PMID:
27863262
14.

Guidelines for Validation of Next-Generation Sequencing-Based Oncology Panels: A Joint Consensus Recommendation of the Association for Molecular Pathology and College of American Pathologists.

Jennings LJ, Arcila ME, Corless C, Kamel-Reid S, Lubin IM, Pfeifer J, Temple-Smolkin RL, Voelkerding KV, Nikiforova MN.

J Mol Diagn. 2017 May;19(3):341-365. doi: 10.1016/j.jmoldx.2017.01.011. Epub 2017 Mar 21. Review.

PMID:
28341590
15.

Next-generation sequencing in precision oncology: challenges and opportunities.

Kruglyak KM, Lin E, Ong FS.

Expert Rev Mol Diagn. 2014 Jul;14(6):635-7. doi: 10.1586/14737159.2014.916213. Epub 2014 May 3.

PMID:
24791810
16.

The role of proficiency testing in ensuring quality: findings from the College of American Pathologists Gynecologic Cytopathology Quality Consensus Conference working group 3.

Howell LP, Nayar R, Savaloja L, Tabbara S, Thomas N, Winkler B, Tworek J.

Arch Pathol Lab Med. 2013 Feb;137(2):183-9. doi: 10.5858/arpa.2012-0094-OA.

PMID:
23368860
17.

Performance Comparison of Different Analytic Methods in Proficiency Testing for Mutations in the BRAF, EGFR, and KRAS Genes: A Study of the College of American Pathologists Molecular Oncology Committee.

Moncur JT, Bartley AN, Bridge JA, Kamel-Reid S, Lazar AJ, Lindeman NI, Long TA, Merker JD, Rai AJ, Rimm DL, Rothberg PG, Vasalos P, Kim AS.

Arch Pathol Lab Med. 2019 Apr 10. doi: 10.5858/arpa.2018-0396-CP. [Epub ahead of print]

PMID:
30969158
18.

Next-Generation Sequencing in Oncology in the Era of Precision Medicine.

Blumenthal GM, Mansfield E, Pazdur R.

JAMA Oncol. 2016 Jan;2(1):13-4. doi: 10.1001/jamaoncol.2015.4503. No abstract available.

PMID:
26540172
19.

Monitoring and ordering practices for human papillomavirus in cervical cytology: findings from the College of American Pathologists Gynecologic Cytopathology Quality Consensus Conference working group 5.

Booth CN, Bashleben C, Filomena CA, Means MM, Wasserman PG, Souers RJ, Henry MR.

Arch Pathol Lab Med. 2013 Feb;137(2):214-9. doi: 10.5858/arpa.2012-0114-CP. Review.

PMID:
23368863
20.

Next-generation sequencing: hype and hope for development of personalized radiation therapy?

Tinhofer I, Niehr F, Konschak R, Liebs S, Munz M, Stenzinger A, Weichert W, Keilholz U, Budach V.

Radiat Oncol. 2015 Aug 28;10:183. doi: 10.1186/s13014-015-0481-x. Review.

Supplemental Content

Support Center